INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

1,143 studies · page 1 of 48

2024 / Narrative review

Gut hormones regulate appetite and weight, while drugs targeting their receptors and environmental factors influence these pathways.

This review summarizes recent research on how gut hormones interact with the brain to influence appetite and body weight. Ghrelin acts as an orexigenic hormone, while GLP-1, GIP, CCK, PYY, and OXM act as anorexigenic hormones, with actions extending into systems such as adipose tissue and high-order thinking. Environmental factors, including meal schedule, food contents and quality, exercise type, and sleep deprivation, influence these gut hormone pathways. Additionally, studies show that retatrutide (a triple-agonist of GLP-1, GIP, and glucagon receptor) and orforglipron (a GLP-1 receptor partial agonist) promote weight loss and improve metabolic parameters associated with obesity.

Hong SH, Choi KM Curr Opin Endocrinol Diabetes Obes, 2024. PMID 38511400

2024 / Narrative review

Gut microbiota and its metabolites interact with incretin hormones to influence host satiety, food intake, and metabolic regulation in obesity.

This review examines the relationships between incretin hormones, gut microbiota, and obesity. Gastrointestinal incretins such as GIP and GLP-1 are secreted following nutrient intake and impact lipid metabolism, gastric emptying, appetite, and body weight. The gut microbiota influences host metabolism by modulating incretin secretion via enteroendocrine cells, with microbial metabolites like short-chain fatty acids and indole directly stimulating incretin release. Additionally, incretin-based therapies and bariatric surgery are associated with increases in gut bacterial richness and diversity.

Angelini G, Russo S, Mingrone G Peptides, 2024. PMID 38636809

2023 / Narrative review

A review outlines the benefits and uncertainties of new weight loss drugs, noting profound caloric reductions may warrant nutritional deficiency testing.

This review evaluates the pros and cons of newer weight loss medications like semaglutide and tirzepatide, noting short-term weight losses of -15% to -20% from baseline. The authors note that profound caloric reductions from these medications should prompt baseline or ongoing nutritional deficiency testing and dietary recommendations. However, long-term adherence, cost, access, supply chain issues, and long-term impacts on mental and physical health remain unknown.

Moyad MA Curr Urol Rep, 2023. PMID 37659049

2023 / Narrative review

A review outlines therapeutic milestones in obesity management, including leptin, melanocortin agonists, incretins, and metabolic surgery.

This review summarizes scientific milestones and therapies developed to address obesity and its cardiometabolic comorbidities. It highlights key developments starting from the discovery of leptin, melanocortin receptor agonists for syndromic obesity, incretin therapies including GLP-1 analogs and unimolecular combinations, and metabolic and bariatric surgery. The authors emphasize that this expanding therapeutic armamentarium warrants a coordinated multidisciplinary approach, such as cardiometabolic expertise centers, to address obesity and its complications.

Kokkorakis M, Katsarou A, Katsiki N, et al. Metabolism, 2023. PMID 37689110

2023 / Review

A review discusses current and emerging anti-obesity medications, including lipase inhibitors, GLP-1 agonists, leptin analogs, and MC4R agonists.

Obesity is a major public health concern associated with conditions like hypertension, type 2 diabetes, stroke, and cancer, affecting over a third of adults in the United States. While standard pharmacological agents such as lipase inhibitors and GLP-1 receptor agonists reduce weight gain by inhibiting fat absorption or stimulating satiety hormones, they are not effective for genetic disorders like Bardet-Biedl syndrome or POMC deficiency. Emerging therapies, including leptin analogs and MC4R agonists, target these genetic or hormonal causes to help regulate energy balance and appetite. The review discusses clinical trials, efficacy, FDA-approved indications, contraindications, and serious side effects of these medication classes.

Brandfon S, Eylon A, Khanna D, et al. Cureus, 2023. PMID 37937009

2023 / Editorial

Obesity and weight loss involve complex interactions between metabolism, the microbiome, social factors, physical comorbidities, and mental health.

This editorial discusses the multifaceted challenges surrounding weight loss and obesity in science and public health. It highlights that both biological aspects (such as metabolism and the microbiome) and social factors (like poverty and inadequate healthcare) contribute to obesity. While excess weight carries comorbidities that reduce life expectancy, evidence indicates individuals can be overweight and healthy, though obesity remains linked to poor mental health influenced by societal stigma.

Thorp HH Science, 2023. PMID 38096295

2022 / Narrative review

GLP-1 receptor agonists are effective for obesity and T2DM, but their therapeutic effects are not fully congruent with endogenous GLP-1 actions.

This review examines the physiological functions of GLP-1 and its development into pharmaceuticals for obesity and type 2 diabetes (T2DM). GLP-1 receptor agonists are highlighted as effective anti-obesity agents and recommended second-line therapies for T2DM, particularly for patients with increased cardiovascular risk. The author discusses proglucagon processing across tissues and notes that the relationship between endogenous GLP-1 actions and the clinical effects of agonists is far from congruent and generally poorly understood.

Holst JJ J Intern Med, 2022. PMID 34982496

2020 / Narrative review

Features of processed foods are linked to western diseases and may negatively affect the gut microbiota.

This review examines literature regarding the relationship between features of processed foods and the etiology of obesity and non-communicable diseases. The reviewed features include micronutrient and energy density, food additives, and the generation of advanced glycation end products from thermal processing. Overall, literature indicates these factors can be linked to western ailments and can have a potential negative impact on human microbiota. The authors propose that empirical evidence is growing for distressed gut microbiota as a mechanism explaining how food processing features could harm human health.

Shows an association, not proof of cause and effect.

Miclotte L, Van de Wiele T Crit Rev Food Sci Nutr, 2020. PMID 30945554

2020 / Narrative review

A review notes that fenugreek extract and its bioactive compounds exhibit antidiabetic and anti-obesity activities in animal and human studies.

This review explores the bioactivity, clinical application, phytochemicals, products, markets, and patents related to fenugreek. More than 100 phytochemicals have been isolated from fenugreek seeds, mainly comprising polysaccharides, saponins, alkaloids, phenolic acids, and flavonoids. Fenugreek extract and its bioactive compounds showed antidiabetic and anti-obesity activity in both animal and human studies. The authors note that China currently lacks research on fenugreek in both depth and width.

Yao D, Zhang B, Zhu J, et al. Crit Rev Food Sci Nutr, 2020. PMID 31286789

2020 / Narrative review

Hospitals can serve as models for dietary change by using patient experiences to educate on lifestyle and optimal nutrition.

Poor dietary quality is a primary contributor to US mortality and cardiovascular risk factors. Hospitals have an opportunity to utilize the patient experience as a teachable moment by educating on lifestyle and dietary changes. Additionally, the food choices offered to inpatients and outpatients can establish a paradigm for patients to adopt following discharge, with several US hospitals demonstrating novel initiatives.

Aggarwal M, Grady A, Desai D, et al. Am J Med, 2020. PMID 31494109

2020 / Literature review

A literature review found that oats show beneficial effects on human gastrointestinal health, altering fecal bacteria and short-chain fatty acids.

A literature review searched PubMed for studies evaluating the effects of oats on gastrointestinal health, identifying 8 human, 19 animal, and 5 in vitro studies. In humans, an amount providing 2.5 to 2.9 g/day of β-glucan decreased fecal pH and altered fecal bacteria, while 40 to 100 g/day of oat bran increased fecal bacterial mass and short-chain fatty acids. The review noted that differences in study design, methodology, and types of oats tested make valid comparisons difficult.

Korczak R, Kocher M, Swanson KS Nutr Rev, 2020. PMID 31638148

2020 / Review of prospective longitudinal cohort studies

A review of longitudinal studies identified 11 modifiable factors, including caffeine, dairy, and vitamin E, linked to Parkinson's disease risk or progression.

This review examined environmental, lifestyle, dietary, comorbid, and pharmacological factors investigated in longitudinal cohort studies regarding the development, progression, and subtypes of Parkinson's disease (PD). Findings indicate that only 11 factors possess sufficient epidemiological evidence and biological plausibility, with pesticides, dairy products, and β2-adrenoreceptor antagonists identified as risk factors. Protective factors identified were smoking, caffeine and tea intake, physical activity, gout, vitamin E intake, NSAIDs, and β2-adrenoreceptor agonists. Caffeine intake and physical activity also appeared to slow PD progression, while modifiable risk factors for PD subtypes remain almost unknown.

Shows an association, not proof of cause and effect.

Belvisi D, Pellicciari R, Fabbrini G, et al. Neurobiol Dis, 2020. PMID 31706021

2020 / Narrative review

Potassium-enriched salt substitutes lower systolic and diastolic blood pressure, but evidence on hyperkalemia risk remains insufficient.

This review evaluated the benefits and risks of replacing sodium chloride with potassium-enriched salt substitutes. Empirical evidence shows that this replacement lowers systolic blood pressure by an average net delta of -5.58 mm Hg (95% CI: -7.08 to -4.09) and diastolic blood pressure by -2.88 mm Hg (95% CI: -3.93 to -1.83). Potential risks include hyperkalemia, arrhythmias, and sudden cardiac death, especially in individuals with impaired potassium excretion such as chronic kidney disease. However, the authors note there is currently insufficient evidence regarding the effects of these substitutes on the occurrence of hyperkalemia.

Greer RC, Marklund M, Anderson CAM, et al. Hypertension, 2020. PMID 31838902

2020 / Commentary / narrative review

A commentary critiques recent recommendations on red and processed meat, highlighting evidence for cardiovascular and cancer risks.

This commentary criticizes five papers in the Annals of Internal Medicine that advised no need to reduce red or processed meat consumption based on low-certainty evidence from randomized trials and cohort studies. The author argues that red meat is a probable human carcinogen, processed meat is a definite carcinogen, and saturated fat raises heart disease risk. Additionally, the piece notes that vegetarians and vegans display superior lipid profiles, decreased chronic disease risk, and longer lifespans compared to meat eaters.

Potter JD, Jackson R Nutr Cancer, 2020. PMID 31842617

2020 / Narrative review

A narrative review suggests ultra-processed Western diet components may influence metabolic and neurobiological pathways relevant to eating disorders.

This narrative review examined the implications of changing dietary patterns, specifically the rise of ultra-processed (NOVA-4) foods, on metabolic and neurobiological pathways related to eating disorders. The increased intake of sugars and food additives has metabolic consequences, including triggering insulin and glucose responses, stimulating appetite, and affecting endocrine pathways, neurobiology, and the microbiome. The authors propose integrating metabolic responses to modern highly processed foods into existing psychological models to improve eating disorder research and treatment outcomes.

Ayton A, Ibrahim A Nutr Rev, 2020. PMID 31846028

2020 / Narrative review

Plant-based and vegan diets are linked to lower disease incidence, though mortality rates are comparable to vegetarians and occasional meat eaters.

This review examined studies addressing mortality, health-span, and longevity-enhancing mechanisms in vegans and vegetarians. Epidemiologic studies consistently show lower disease rates, such as lower cancer and cardiovascular disease incidence, but mortality rates are comparable to vegetarians and occasional meat eaters. Vegan diets improve insulin resistance and dyslipidemia, and features like protein restriction or amino acid restriction (leucine or methionine) show potential life-span-enhancing effects. The review notes that vegan diets do not meet the nutritional requirements of children, pregnant women, or elderly individuals without adequate supplementation.

Shows an association, not proof of cause and effect.

Norman K, Klaus S Curr Opin Clin Nutr Metab Care, 2020. PMID 31895244

2020 / Narrative review

Precision nutrition aims to stratify populations into biomarker-based subgroups to improve dietary recommendations rather than create individual prescriptions.

This review discusses precision nutrition, which aims to stratify individuals into population subgroups based on biomarkers of metabolic variation such as genetics, epigenetics, the microbiome, lifestyle, diet, and environment. The authors focus primarily on genetically related sources of metabolic heterogeneity to better estimate subgroup dietary requirements. It also addresses challenges in understanding interactions among diverse sources of metabolic heterogeneity and touches upon commercial applications.

Zeisel SH Annu Rev Food Sci Technol, 2020. PMID 31928426

2020 / Narrative review / methodological commentary

NutriGRADE evaluation rated evidence linking red and processed meats to type 2 diabetes as high quality and to mortality as moderate quality.

This commentary assesses the NutriRECS consortium's recommendations on red and processed meat, arguing their evaluation relied on GRADE criteria primarily designed for clinical drug trials rather than dietary exposures. Applying the NutriGRADE system, the evidence on the positive association between red and processed meats and type 2 diabetes was rated 'high quality,' and the association with mortality was rated 'moderate quality.' The authors note NutriRECS's evaluation also suffered from inadequate attention to what foods replace red meat, such as plant-based proteins or refined carbohydrates.

Shows an association, not proof of cause and effect.

Qian F, Riddle MC, Wylie-Rosett J, et al. Diabetes Care, 2020. PMID 31959642

2020 / Narrative review

A whole food plant-based diet may offer benefits that slow chronic kidney disease progression and delay kidney failure.

This review examines the potential of a whole food plant-based (WFPB) diet to ameliorate chronic kidney disease (CKD). Evidence suggests a WFPB diet may slow CKD progression, decrease cardiovascular disease incidence, lower rates of diabetes and obesity, and reduce inflammation and cholesterol, thereby delaying kidney failure and dialysis initiation. Plant-based protein is reported to be alkaline-producing, anti-inflammatory, and renoprotective, contrasting with animal protein which promotes acidity, inflammation, and hyperfiltration. The authors note that macronutrient and micronutrient content must be carefully adjusted to prevent malnutrition, and further research is required to confirm biological plausibility and feasibility in CKD patients.

Adair KE, Bowden RG Nutrients, 2020. PMID 32268544

2020 / Narrative review

A review indicates high sodium intake is directly related to increased blood pressure, target organ damage, and elevated cardiovascular risk.

This review examines evidence on sodium intake and target organ damage in hypertension. The authors report that current global sodium consumption exceeds safe levels and that sodium intake is directly related to increased blood pressure and independently to cardiac mass enlargement. High sodium intake may also induce renal damage progression in both hypertensive and normotensive individuals and play an adverse role in cerebrovascular disease.

Nista F, Gatto F, Albertelli M, et al. Int J Environ Res Public Health, 2020. PMID 32325839

2020 / Guideline

The American Cancer Society updated its diet and physical activity guidelines for cancer prevention, adding community action recommendations.

The American Cancer Society updated its Diet and Physical Activity Guideline based on current scientific evidence regarding dietary and physical activity patterns and cancer risk. The guideline presents 4 recommendations for individual choices alongside recommendations for community action to create supportive environments. These recommendations align with prevention guidelines for coronary heart disease and diabetes from the American Heart Association and the American Diabetes Association.

Rock CL, Thomson C, Gansler T, et al. CA Cancer J Clin, 2020. PMID 32515498

2020 / Narrative review

A review notes lifestyle modifications like low sodium diet and weight loss can help control hypertension in African Americans.

This review examined literature from PubMed, guideline reports, and newer publications regarding hypertension and COVID-19 in African Americans. It highlights that the increased prevalence and risks of hypertension are primarily due to environmental and lifestyle factors, such as poor diet and adverse social determinants. Blood pressure control can be supported through lifestyle changes, including a low-sodium diet, weight loss, and physical activity, alongside pharmacological or novel treatments when needed. Additionally, existing comorbidities like hypertension and obesity contribute to worse COVID-19 outcomes in this population.

Ferdinand K, Batieste T, Fleurestil M J Natl Med Assoc, 2020. PMID 32563685

2020 / Narrative review with systematic search

A review of 43 studies found ultra-processed food consumption was linked to at least one adverse health outcome in 37 studies, with no beneficial outcomes found.

This narrative review systematically searched and appraised studies examining associations between ultra-processed food (UPF) intake and health outcomes in healthy participants. Out of 43 reviewed studies, 37 found UPF exposure was associated with at least one adverse health outcome. In adults, reported associations included overweight, obesity, cardio-metabolic risks, cancer, type-2 diabetes, cardiovascular diseases, irritable bowel syndrome, depression, frailty conditions, and all-cause mortality; in children and adolescents, outcomes included cardio-metabolic risks and asthma. No study reported an association between UPF and beneficial health outcomes, and the authors note that most findings were derived from observational studies.

Shows an association, not proof of cause and effect.

Elizabeth L, Machado P, Zinöcker M, et al. Nutrients, 2020. PMID 32630022